Clinical Trial Update: Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update describes a dual-target CAR-T therapy that targets mesothelin and Claudin-18.2 for advanced pancreatic cancer, with recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Dual-target Mesothelin/Claudin-18.2 CAR-T therapy

Snippet

Sponsor: Essen Biotech | Conditions: Pancreatic Cancer, Pancreatic Carcinoma | Phase 1, Phase 2 | Status: RECRUITING